) reported a decline in first-quarter profits and slashed its full-year earnings outlook, sending shares down more than 11% premarket as both earnings and revenue fell short of Wall Street expectations. The healthcare giant posted adjusted earnings per share of $1.33 for the quarter, which was significantly below the analysts' consensus of $1.71. Revenue for the quarter was $88.4 billion, also missing the consensus estimate of $89.33 billion.
CVS Health's President and CEO, Karen S. Lynch, commented on the results, stating, "The current environment does not diminish our opportunities, enthusiasm, or the long-term earnings power of our company. We are confident we have a pathway to address our near-term Medicare Advantage challenges." She emphasized the company's commitment to its strategy and belief in its assets to deliver value despite near-term pressures.
The stock's significant drop following the earnings release indicates investor concerns over the company's revised earnings forecast and current quarter performance. CVS Health's guidance adjustment and the first-quarter results have set a cautious tone for the company's financial outlook for the remainder of the year.
Colombia Últimas Noticias, Colombia Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Fuente: CNBC - 🏆 12. / 72 Leer más »